Atopic dermatitis is a prevalent chronic inflammatory skin condition affecting up to 20% of children and 10% of adults in Africa. The management of atopic dermatitis relies heavily on the use of emollients, which form the foundation of treatment by enhancing the skin barrier and preventing the condition's flare-ups. However, access to emollients remains a significant challenge across Africa, impeding effective treatment and worsening the QOL in those affected. This research utilized a cross-sectional survey conducted between October 2023 and April 2024, gathering data from dermatologists in 16 African countries. Information was collected regarding the availability of traditional and industrial emollients, costs, economic conditions, and healthcare infrastructure. Results indicate that traditional emollients such as coconut oil and shea butter are widely available, although their quality and consistency vary. Imported emollients, including Vaseline petroleum jelly and products from brands such as Dexeryl, Topicrem, and CeraVe, are more commonly prescribed. However, the cost of these imported products is a significant barrier. In conclusion, this study highlights significant disparities and major economic barriers to accessing emollient treatments for atopic dermatitis in Sub-Saharan Africa.
Keywords: Accessibility; Africa; Atopic dermatitis; Emollients.
Copyright © 2026. Published by Elsevier Inc.